Levofloxacin Plus Metronidazole Suppositories
PreclinicalSmall molecule
Levofloxacin Plus Metronidazole Suppositories is one of 8 small molecule programs targeting Endometritis. It is currently in Preclinical.
1
Indications
1
Total Trials
1
Active Trials
7
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
8 competitors in Endometritis
#DrugCompanyPhaseTrials
1Acanya
PfizerApproved
Ancef
BBaxter Healthcare Corporation
Approved
Invanz
CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)
Approved
Rocephin
CConrado Roberto Hoffmann Filho
Approved
Zithromax
PPfizer's Upjohn has merged with Mylan to form Viatris Inc.
Preclinical
Peridex
DDexcel Pharma Technologies Ltd.
Preclinical
Antibiotics
MMelinta Therapeutics, Inc.
Preclinical
Levofloxacin Plus Metronidazole Suppositories
PPeking University Third Hospital
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- PPeking University Third Hospital